-transparent.png){kind=logo}
We report about 50 patients with inoperable bronchus tumors treated since March 1986 in a prospective non randomized study with high dose rate iridium-192 afterloading (AL) irradiation in 140 applications. 26 patients were treated combined with external irradiation. 32 were treated before with laser therapy, one with chemotherapy (small cell carcinoma). The actuarial survival rate (Kaplan-Meier) was 26% after 36 weeks for all patients; 38% for combined endoluminal and external irradiation and 9% for patients treated with AL alone. Death was caused by the local tumor in 85%. In 41% lethal bleeding was seen.
Related Publications
H Schedel, and
R Rohloff, and
R M Huber, and
S Duft, and
R Kantlehner
June 1988,
Praxis und Klinik der Pneumologie,
H Schedel, and
R Rohloff, and
R M Huber, and
S Duft, and
R Kantlehner
January 2002,
The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society,
H Schedel, and
R Rohloff, and
R M Huber, and
S Duft, and
R Kantlehner
June 1992,
Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica,
H Schedel, and
R Rohloff, and
R M Huber, and
S Duft, and
R Kantlehner
September 1990,
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
H Schedel, and
R Rohloff, and
R M Huber, and
S Duft, and
R Kantlehner
March 1991,
Pneumologie (Stuttgart, Germany),
H Schedel, and
R Rohloff, and
R M Huber, and
S Duft, and
R Kantlehner
April 1980,
International journal of radiation oncology, biology, physics,
H Schedel, and
R Rohloff, and
R M Huber, and
S Duft, and
R Kantlehner
August 1984,
Strahlentherapie,
H Schedel, and
R Rohloff, and
R M Huber, and
S Duft, and
R Kantlehner
December 1993,
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
H Schedel, and
R Rohloff, and
R M Huber, and
S Duft, and
R Kantlehner
September 1989,
Medical dosimetry : official journal of the American Association of Medical Dosimetrists,
H Schedel, and
R Rohloff, and
R M Huber, and
S Duft, and
R Kantlehner
August 1984,
Onkologie,
